Holen Sie sich die Stockscreener-App
0.5701
9.63%
0.0501
Schlusskurs vom Vortag:
$0.52
Offen:
$0.5201
24-Stunden-Volumen:
1,311
Relative Volume:
2.29
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.16M
KGV:
-0.1654
EPS:
-3.4464
Netto-Cashflow:
$-4.14M
1W Leistung:
-18.56%
1M Leistung:
-61.18%
6M Leistung:
-82.90%
1J Leistung:
-90.59%
1-Tages-Spanne:
$0.5201
$0.676
1-Wochen-Bereich:
$0.5003
$0.75
52-Wochen-Spanne:
$0.5003
$0.75
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Firmenname
Protagenic Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare PTIX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
0.5701 | 0 | 0 | -5.16M | -4.14M | -3.4464 |
VRTX
Vertex Pharmaceuticals Inc
|
447.26 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
777.25 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
743.12 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.73 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.86 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten
EV Market: Whats the beta of Protagenic Therapeutics Inc stockQuarterly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Aug Summary: What is the long term forecast for Protagenic Therapeutics Inc stockTrade Volume Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
Aug Setups: Is Protagenic Therapeutics Inc Equity Warrants growth already priced in2026 Retail Activity & Weekly Top Performers Watchlists - baoquankhu1.vn
US Stocks Recap: Can Protagenic Therapeutics Inc Equity Warrant maintain sales growth2026 Chart Watch & High Conviction Buy Zone Picks - baoquankhu1.vn
Gainers Report: Whats the profit margin of Protagenic Therapeutics Inc Equity Warrant2026 Key Lessons & Growth Focused Entry Point Reports - baoquankhu1.vn
Volume Summary: Does Protagenic Therapeutics Inc align with a passive investing strategyGlobal Markets & Daily Chart Pattern Signals - baoquankhu1.vn
If You Invested $1,000 in Protagenic Therapeutics Inc (PTIX) - stocktitan.net
Options Flow: Is Protagenic Therapeutics Inc being accumulated by smart money2026 Trends & Consistent Profit Trading Strategies - baoquankhu1.vn
Trading Recap: Why is Protagenic Therapeutics Inc stock going downQuarterly Trade Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Protagenic settles Phytanix separation, cuts liabilities by $6.3M - Investing.com
Protagenic Therapeutics (PTIX) Streamlines Operations and Focuses on Key Asset - GuruFocus
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 - guardonline.com
Protagenic slashes $6.3M liabilities to focus on new depression treatment - Stock Titan
Market Pulse: Whats the profit margin of Protagenic Therapeutics Inc Equity WarrantWeekly Profit Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Protagenic Therapeutics Upgrades to OTCQB Venture Market - National Today
Protagenic Therapeutics (PTIX) Upgrades to OTCQB Market - GuruFocus
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market - ACCESS Newswire
Protagenic biotech gains OTCQB listing as depression drug nears Phase 2 - Stock Titan
Protagenic Therapeutics, Inc. (PTIX) 10-Q Quarterly Report for December 31, 2025 – Financials, Filings, and Nasdaq Listing - Minichart
Protagenic Therapeutics 10-Q: $0 Revenue, $1.14 EPS, operating loss $0.93M - TradingView
Protagenic Therapeutics : Quarterly Report for Quarter Ending December 31, 2025 (Form 10-Q) - marketscreener.com
Protagenic Therapeutics (PTIX) posts derivative-driven profit but warns on going concern - Stock Titan
Why Protagenic Therapeutics Inc. Equity Warrant stock is a value investor pick2026 Price Targets & Smart Investment Allocation Tips - Naître et grandir
Aug Action: Whats the beta of Protagenic Therapeutics Inc stockMarket Growth Report & Free High Return Stock Watch Alerts - baoquankhu1.vn
Earnings Report: Is Protagenic Therapeutics Inc Equity Warrant a momentum stock2025 Major Catalysts & Accurate Trade Setup Notifications - baoquankhu1.vn
Protagenic Therapeutics Appoints William Nichols as President - The Globe and Mail
Atrinsic (NASDAQ:PTIX) Shares Up 10.9% – Should You Buy? - Defense World
Protagenic Therapeutics appoints William Nichols Jr. as president - Investing.com
Protagenic Therapeutics (OTC: PTIX) appoints William Nichols as President - stocktitan.net
Protagenic Therapeutics announces delay in quarterly filing - TipRanks
Atrinsic (NASDAQ:PTIX) Trading Down 0.6% – Here’s What Happened - Defense World
Protagenic Therapeutics (NASDAQ: PTIX) stock and warrants removed from Nasdaq listing - stocktitan.net
Inflation Data: Whats the profit margin of Protagenic Therapeutics Inc Equity WarrantInflation Watch & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Hedge Fund Bets: What’s the beta of U.S. Bancorp Preferred Security stockWeekly Profit Report & Safe Capital Preservation Plans - baoquankhu1.vn
Aug Decliners: Is Protagenic Therapeutics Inc Equity Warrant stock resilient to inflationQuarterly Earnings Report & Community Verified Swing Trade Signals - Bộ Nội Vụ
Sentiment Watch: Can Protagenic Therapeutics Inc Equity Warrant stock outperform in 2025 bull market - Bộ Nội Vụ
Layoff Watch: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryJuly 2025 Summary & Verified Technical Trade Signals - Bộ Nội Vụ
Performance Recap: Is Protagenic Therapeutics Inc Equity Warrant stock a good choice for value investorsJuly 2025 Macro Moves & Advanced Technical Analysis Signals - Bộ Nội Vụ
Why Protagenic Therapeutics Inc. stock remains undervaluedJuly 2025 Earnings & Accurate Intraday Trading Signals - Улправда
Is Protagenic Therapeutics Inc. Equity Warrant stock a contrarian buyQuarterly Growth Report & Breakout Confirmation Alerts - Улправда
Total assets of Protagenic Therapeutics, Inc. – OTC:PTIXW - TradingView — Track All Markets
Why Protagenic Therapeutics Inc. Equity Warrant stock is a must watch in 2025Market Movement Recap & Weekly Stock Breakout Alerts - Улправда
How Protagenic Therapeutics Inc. Equity Warrant stock performs in weak economyMarket Growth Review & Real-Time Buy Signal Notifications - Улправда
Trading Action: Is Protagenic Therapeutics Inc. Equity Warrant stock recession proof2025 Volatility Report & Low Risk Investment Opportunities - Улправда
Can Protagenic Therapeutics Inc. Equity Warrant stock continue upward trendMarket Sentiment Summary & Daily Risk Controlled Trade Plans - ulpravda.ru
Can Protagenic Therapeutics Inc. stock hit analyst price targetsGDP Growth & Long-Term Safe Investment Ideas - Улправда
Is Protagenic Therapeutics Inc. Equity Warrant stock affected by interest rate hikes2025 Short Interest & Weekly Breakout Watchlists - Улправда
Is Protagenic Therapeutics Inc. Equity Warrant stock a good choice for value investorsPortfolio Return Summary & Step-by-Step Trade Execution Guides - ulpravda.ru
Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 Price Swings & Long-Term Safe Return Strategies - Улправда
How Protagenic Therapeutics Inc. stock trades during market volatilityPortfolio Performance Summary & Weekly Breakout Watchlists - Улправда
Market Rankings: Is Protagenic Therapeutics Inc. Equity Warrant stock affected by interest rate hikesWeekly Risk Summary & Real-Time Stock Price Movement Reports - Улправда
Finanzdaten der Protagenic Therapeutics Inc-Aktie (PTIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
0.51%
Kapitalisierung:
|
Volumen (24h):